Mer­ck seeks more ap­provals for in­fec­tious dis­ease drug

Phar­ma gi­ant Mer­ck is look­ing to bag more in­di­ca­tions for its cy­tomegalovirus (CMV) treat­ment Pre­vymis.

The phar­ma an­nounced on Fri­day that the FDA has ac­cept­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER